Day One Biopharmaceuticals, Inc.
DAWN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,186,210 | $1,164,686 | $1,408,845 | $1,043,896 |
| - Cash | $124,968 | $230,784 | $85,262 | $284,309 |
| + Debt | $2,602 | $408 | $813 | $220 |
| Enterprise Value | $1,063,844 | $934,310 | $1,324,396 | $759,807 |
| Revenue | $131,161 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $125,882 | -$383 | -$531 | -$199 |
| % Margin | 96% | – | – | – |
| EBITDA | -$86,323 | -$188,534 | -$141,650 | -$72,555 |
| % Margin | -65.8% | – | – | – |
| Net Income | -$95,496 | -$188,917 | -$142,181 | -$70,645 |
| % Margin | -72.8% | – | – | – |
| EPS Diluted | -1.02 | -2.37 | -2.02 | -1.14 |
| % Growth | 57% | -17.3% | -77.2% | – |
| Operating Cash Flow | -$78,113 | -$146,853 | -$109,874 | -$48,539 |
| Capital Expenditures | -$2,169 | -$3,224 | -$26 | -$8,000 |
| Free Cash Flow | -$80,282 | -$150,077 | -$109,900 | -$56,539 |